Immunotherapy

Gamma-delta T Cells CAR T Therapy Neoantigen Therapy Pembrolizumab Personalized Immunotherapy mRNA vaccine

Experimental mRNA Vaccine Extends Survival in Glioblastoma Patients

A novel mRNA vaccine has shown promising results in extending the survival of patients with glioblastoma, a deadly brain cancer, by activating rapid immune responses.

10 ARTICLES

last yr.

UK Begins Final Trials of Groundbreaking Personalized mRNA Cancer Vaccine

11 ARTICLES

last yr.

Early Clinical Trials Show Promise in Shrinking Glioblastoma with CAR-T Therapy